We are live on ! Find out more
AXN

Aoxing Pharmaceutical Company Inc.
AXN

Delisted

AXN was delisted on the 16th of October, 2017.

Back to rankings

2 hedge funds and large institutions have $17K invested in Aoxing Pharmaceutical Company Inc. in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more capital invested

Capital invested by funds: $12K → $17K (+$5K)

33% less funds holding

Funds holding: 3 → 2 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$13.1K

Top Sellers

Rank Fund Capital Flow
1
CA
Cetera Advisors
Colorado
-$7K
2
U
UBS
Switzerland
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$14K +$13.1K +53,449 New
EWM
2
Evercore Wealth Management
New York
$3K – – –
CA
3
Cetera Advisors
Colorado
– -$7K -30,760 Closed
U
4
UBS
Switzerland
– -$2K -8,585 Closed

AXN Hedge Fund Activity: Q3 2013 in Review

2 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Aoxing Pharmaceutical Company Inc. (AXN) for Q3 2013, worth a combined $17K — up 42% from $12K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of AXN and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $13.1K. The largest seller was Cetera Advisors, exiting entirely with an estimated $7K sold.

  • 2 institutional investors held Aoxing Pharmaceutical Company Inc. (AXN) as of Q3 2013, down from 3 in Q2 2013.
  • Funds reported $17K of Aoxing Pharmaceutical Company Inc. stock for Q3 2013, up 42% quarter-over-quarter.
  • 1 fund opened new Aoxing Pharmaceutical Company Inc. positions in Q3 2013 and 2 closed out, a net change of -1 holder.
  • The largest Aoxing Pharmaceutical Company Inc. buyer in Q3 2013 was Citadel Advisors, an estimated $13.1K added.
  • The largest Aoxing Pharmaceutical Company Inc. seller in Q3 2013 was Cetera Advisors, an estimated $7K sold.

Based on aggregated 13F filings for Q3 2013.